PA
HONE

PharVision Advisers’s HarborOne Bancorp HONE Stock Holding History

PharVision Advisers’s Portfolio HONE Stock Details HONE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,260
Closed -$240K – 386
2024
Q4 		$240K Buy
+20,260
New +$257K 0.2% 238

Other funds holding HONE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PharVision Advisers's HONE Position: Q1 2025 in Review

PharVision Advisers sold out of HarborOne Bancorp (HONE) in Q1 2025, closing a stake of 20,260 shares — an estimated $240K sold.

PharVision Advisers first reported a position in HONE in Q4 2024 and held it in 1 quarter. The position peaked at $240K in Q4 2024. 137 funds tracked by Wall St. Rank hold HONE as of Q1 2025.

  • PharVision Advisers reported no remaining HarborOne Bancorp position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 20,260 HarborOne Bancorp shares in Q1 2025, an estimated $240K.
  • PharVision Advisers first reported a position in HarborOne Bancorp in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's HarborOne Bancorp position peaked at $240K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held HarborOne Bancorp as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.